FESOTERODIN Zentiva cpr ret 8 mg 14 pce
7680686940031
CH-68694
G04BD11
05.02.0.
1 / 3
google
Details
- Product number
- 6869402
- CPT
- -
- Packaging group
- 14
- Unit
- Tablette(n)
- Composition
- fesoterodini fumaras 8 mg corresp. fesoterodinum 6.2 mg, glyceroli dibehenas, hypromellosum, talcum, lactosum monohydricum 124.125 mg, cellulosum microcristallinum, Überzug: poly(alcohol vinylicus), talcum, E 171, E 132, E 172 (rubrum), glyceroli monocaprylocapras, natrii laurilsulfas, pro compresso obducto corresp. natrium 0.046 mg.
Articles (1)
Fesoterodin Zentiva 8 mg, Retardtabletten
Tabletten
14
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
8.0 MG | Substance | WIZUS |
|
(N/A)
|
6.2 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
124.125 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
0.046 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 26.70
Specialties list
Yes
Generic
Yes
SL addition date:
01/01/2024
Authorization holder
Helvepharm AG
8500 Frauenfeld
Authorization information
- Swissmedic authorization number
- 68694
- Drug name
- Fesoterodin Zentiva, Retardtabletten
- Galenic form
- RETT
- ATC Code
- G04BD11
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 31/03/2022
- Authorization expiration date
- 30/03/2027
- IT number
- 05.02.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FESOTERODIN Zentiva cpr ret 8 mg 14 pce
- Description (DE)
- FESOTERODIN Zentiva Ret Tabl 8 mg 14 Stk
- Market launch
- 31/03/2022
- Narcotic (BTM)
- No